C-REX®

With zero leakage in mind

We are aiming to improve

patient outcomes after colorectal cancer surgery

THE CHALLENGE

In current clinical practice

stapling and suturing

are most common techniques for colorectal anastomosis

Colorectal surgeries globally per year

3.3M

8.6%*

Of surgeries will be complicated by anastomotic leakage

An estimate of $9bn will be spent annually worldwide to treat

complications of leakage **

The increasing number of adverse events after surgeries with stapling

is causing widespread concern ***

 
THE SOLUTION

Innovative
short-term 

implant

C-REX® family devices help create a robust and adaptive anastomosis

without stapling or compression

throughout colon and rectum

0413

 

Unique 

C-REX® catheter  system

For validation of anastomosis by

objective integrity pressure test and

precise X-ray visualization

during and after surgery

For all types of surgery

C-REX® family devices are designed for laparoscopic, robotic and open surgeries and all types of anastomoses

LapAid®

Use for colon and upper rectum resections

RectoAid®

Use for lower rectum resections and ta-TME

* Results of the international audit by the European Society of Coloproctology (2017)

** Includes additional costs of 30 days after surgery only. Lee et al, Surgical Endoscopy (2019). 

*** FDA's letter to the Health Care Providers, March 8, 2019 

NEWSLETTER

Sign up for news and events

With zero leakage in mind

CarpoNovum AB is a Swedish company

innovating, manufacturing and delivering

a new generation of surgical instruments

for colorectal surgery.

CarpoNovum

Products

Carponovum AB
Olofsdalsvägen 10
302 41 Halmstad, Sweden

Connect

linkedin.png

Company

Change language